Modification of prescribers’ behavior: the Icelandic approach Karl G. Kristinsson Clinical Microbiology and Infection Volume 5, Pages 4S43-4S47 (August 1999) DOI: 10.1111/j.1469-0691.1999.tb00856.x Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 1 Yearly incidence rates for penicillin-non-susceptible pneumococci isolated from patient specimens. Repeat isolates have been excluded. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 2 Quarterly incidence of penicillin-non-susceptible pneumococci of serogroups 6, 19 and 23. The values for serogroup 19 strains also include strains with penicillin MIC of 0.06 mg/L. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 3 Proportion of children carrying pneumococci according to age. The open columns represent pneumococcal carriage, and the shaded columns carriage of penicillin-non-susceptible strains. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions
Figure 4 Antimicrobial use in defined daily dosages (DDD) per 1000 inhabitants per day in Iceland. Clinical Microbiology and Infection 1999 5, 4S43-4S47DOI: (10.1111/j.1469-0691.1999.tb00856.x) Copyright © 1999 European Society of Clinical Infectious Diseases Terms and Conditions